Paper31298147
Composition and Potential Health Benefits of Pomegranate: A Review.
Vučić V and 3 others. Curr Pharm Des, 2019. Cited by 94 papers, by iCite.
Cite this record
ConductScience Library. Composition and Potential Health Benefits of Pomegranate: A Review. Papers, record 31298147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31298147
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fruit | Major topic |
| Pomegranate | Major topic |
| Anti-Inflammatory Agents | |
| Antioxidants | |
| Fruit and Vegetable Juices | |
| Phytochemicals | |
| Plant Extracts |
Source PubMed
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42795530 | The Versatility of Pomegranate: From Phytochemical Diversity to Antimicrobial and Translational Applications. | Microorganisms | 2026 | https://conductscience.org/library/papers/42795530 | PubMed |
| 42153011 | Pomegranate juice consumption and lipid profile: An updated systematic review and meta-analysis. | Avicenna J Phytomed | 2026 | https://conductscience.org/library/papers/42153011 | PubMed |
| 41476712 | Gastroprotective and Antiulcerogenic Impacts of Pomegranates (Punica granatum) Peel Extract: In Vivo and In Vitro Study. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/41476712 | PubMed |
| 41442088 | Waste valorization utilizing green nanotechnology: a sustainable approach for pomegranate peel agro wastes in skincare formulations. | Bioresour Bioprocess | 2025 | https://conductscience.org/library/papers/41442088 | PubMed |
| 41300675 | Phytotherapy in Pediatric Dentistry: A Narrative Review of Clinical Applications and Evidence. | Children (Basel) | 2025 | https://conductscience.org/library/papers/41300675 | PubMed |
| 41287595 | Persian Medicinal Plants as Antidiabetic Agents: Mechanisms and Evidence from Bench to Bedside . | Iran Biomed J | 2025 | https://conductscience.org/library/papers/41287595 | PubMed |
| 41154082 | Identification of Key Aroma Substances in Pomegranate from Different Geographical Origins via Integrated Volatile Profiling and Multivariate Statistical Analysis. | Foods | 2025 | https://conductscience.org/library/papers/41154082 | PubMed |
| 40325813 | Innovative Therapeutic Potential of Herbal Extracts Containing Punicic and Ellagic Acid: Addressing Lower Urinary Tract Disorders. | Curr Mol Med | 2025 | https://conductscience.org/library/papers/40325813 | PubMed |
| 40286243 | Exploring the Influence of a Pomegranate Extract on the Functionality of Healthy and Diseased Human Gut Microbiota: An In Vitro Study. | Molecules | 2025 | https://conductscience.org/library/papers/40286243 | PubMed |
| 40218901 | Pomegranate Juice Alleviates Preeclampsia Symptoms in an L-NAME-Induced Rat Model: A Dose-Dependent Study. | Nutrients | 2025 | https://conductscience.org/library/papers/40218901 | PubMed |
| 40005672 | Diet Supplementation with Pomegranate Fruit Alters Distal Gut Microbiota of Healthy Female College Students. | Microorganisms | 2025 | https://conductscience.org/library/papers/40005672 | PubMed |
| 39814761 | A Chromosome level assembly of pomegranate (Punica granatum L.) variety grown in arid environment. | Sci Data | 2025 | https://conductscience.org/library/papers/39814761 | PubMed |
| 39733205 | Beneficial Effects of Pomegranate Extracts for Benign Gynecologic Disorders. | Reprod Sci | 2025 | https://conductscience.org/library/papers/39733205 | PubMed |
| 39459564 | Therapeutic Potential of Pomegranate Extract for Women's Reproductive Health and Breast Cancer. | Life (Basel) | 2024 | https://conductscience.org/library/papers/39459564 | PubMed |
| 39337431 | Involvement of Aryl Hydrocarbon Receptor in Longevity and Healthspan: Insights from Humans, Mice, and C. elegans. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39337431 | PubMed |
| 39275022 | Pomegranate (Punica granatum L.) Extract Effects on Inflammaging. | Molecules | 2024 | https://conductscience.org/library/papers/39275022 | PubMed |
| 39211783 | Pomegranate flower polysaccharide improves mastitis in mice by regulating intestinal flora and restoring the blood-milk barrier. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39211783 | PubMed |
| 39124256 | Systemic Analyses of Anti-Cell-Senescence Active Compounds in Camellia Sect. Chrysantha Chang and Their Mechanisms. | Plants (Basel) | 2024 | https://conductscience.org/library/papers/39124256 | PubMed |
| 38903205 | Punicalagin Restricts Growth, Promotes Apoptosis, and Reduces Invasion in Human Gastric Cancer Cells. | Dose Response | 2024 | https://conductscience.org/library/papers/38903205 | PubMed |
| 38612967 | Herbal Medicines for the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis. | Nutrients | 2024 | https://conductscience.org/library/papers/38612967 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31298147
GET https://conductscience.org/api/papers/v1/31298147/cited_by?page=2